Results 171 to 180 of about 189,531 (311)

Coercive compliance? Anti-doping systems in tennis and athlete mental health. [PDF]

Front Sports Act Living
Colangelo J, Smith A, Claussen MC, Castaldelli-Maia JM, Liebrenz M.   +4 more
europepmc   +1 more source

Hypnotic doses of fazamorexant induced less impairment on balance and cognition than zolpidem in healthy younger and elderly individualse

British Journal of Clinical Pharmacology, EarlyView.
Aims Fazamorexant is a dual orexin receptor antagonist being developed for the treatment of insomnia. This study aims to determine the dose‐exposure‐response relationship of single‐dose fazamorexant vs. zolpidem in young adult and elderly healthy Chinese volunteers. Methods This single‐centre, randomized, double‐blind, double‐dummy, placebo‐ and active‐
Chen Xia, Huang Xingxing, Jin Lu, Wang Ruwei   +3 more
wiley   +1 more source

Does the Netherlands comply with national law and Article 2 of human rights concerning deceased minors? [PDF]

PLoS One
van Rhenen SCT, Wemeijer TM, Gregoire CAS, Duijst WLJM.   +3 more
europepmc   +1 more source

CORRELATION OF THE ABUSE OF RIGHT AND CRIMINAL PROCEDURAL OFFENSES

Ugolovnaya yustitsiya, 2017
Vladimir A. Azarov, Daulet M. Nurbayev
openaire   +1 more source

On countering the abuse of the procedural rights while using mediation as a conciliation procedure

Electronic Supplement to Russian Juridical Journal, 2022
E. Ivanova, E. Solomeina, T. Khrushcheleva, G. Sheremetova   +3 more
openaire   +1 more source

Low‐dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug–drug interaction study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Cannabidiol (CBD), the main non‐intoxicating compound from the cannabis plant, is regularly used by patients with chronic pain who also take analgesics. CBD has previously been shown to inhibit CYP‐mediated drug metabolism. This study aimed to characterize the potential pharmacokinetic interaction of CBD with amitriptyline and tramadol ...
Andriy A. Gorbenko, Titiaan E. Post, Pamela K. Strugala, Erica S. Klaassen, Linda E. Klumpers, Saco J. de Visser, Cristina Sempio, Jost Klawitter, Jules A. A. C. Heuberger, Geert J. Groeneveld   +9 more
wiley   +1 more source

Barriers to abortion access for young southerners: a qualitative analysis of case notes from ARC-Southeast. [PDF]

BMC Public Health
Larsen C, Njoku O, Labgold K, Jackson J, Rochat R, Rice WS.   +5 more
europepmc   +1 more source

International trafficking in women and children [PDF]

, 2002
Vermeulen, Gert
core  

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

How are sexual orientations, gender identities and expressions, and sex characteristics (SOGIESC) addressed in UN conventions, treaty bodies, and decisions: a scoping review. [PDF]

Global Health
Seppey M, Bodryzlova Y, Mac-Seing M, Girard G, Zarowsky C.   +4 more
europepmc   +1 more source